About the Authors
- Rakesh K Jain
-
*To whom correspondence should be addressed. E-mail: Jain@steele.mgh.harvard.edu
- Johanna Lahdenranta
- Dai Fukumura
Competing Interests
RKJ is a grantee of AstraZeneca and a consultant to AstraZeneca, Dyax, and Pfizer. He has received an honorarium from Roche. JL and DF declare that they have no competing interests.